Product Code: ETC8847437 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The opioid-induced constipation (OIC) drugs market is expanding in the Philippines as the use of opioids for pain management increases. Pharmaceutical companies are introducing targeted treatments to address this common side effect, with prescription and over-the-counter options available.
The Philippines Opioid Induced Constipation Drugs Market is driven by the increasing use of opioids for pain management, leading to a rise in opioid-induced constipation (OIC cases. As more people are prescribed opioids for chronic pain, the demand for medications that specifically target OIC is growing. The market is also influenced by the increasing awareness of the side effects of opioids and the need for effective treatments to improve patients` quality of life while mitigating constipation-related issues.
The opioid-induced constipation (OIC) drugs market in the Philippines faces challenges such as limited availability of treatment options, high drug prices, and low awareness among healthcare providers. While the market for OIC treatment is growing due to the rising opioid usage in the country, treatment options remain limited, and many patients may not receive appropriate care. Additionally, the high cost of specialized medications for OIC makes them less accessible to the general population, particularly in rural areas.
The increasing use of opioid medications for pain management has led to a rising demand for opioid-induced constipation (OIC) treatments. Investors can capitalize on this growing market by developing novel pharmaceutical formulations, including prescription and over-the-counter drugs, that effectively manage OIC without compromising pain relief. Partnerships with healthcare providers and awareness campaigns can further boost market growth.
The Philippine government has implemented various healthcare policies focused on addressing the opioid crisis and its side effects, such as opioid-induced constipation (OIC). These policies aim to ensure the safe use of opioid medications while minimizing their adverse effects. Regulations on the approval, distribution, and prescription of drugs to manage OIC contribute to the growth of the opioid-induced constipation drugs market. Furthermore, government initiatives to provide adequate healthcare services and patient education regarding opioid use support the adoption of these treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Opioid Induced Constipation Drugs Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 Philippines Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Opioid Induced Constipation Drugs Market Trends |
6 Philippines Opioid Induced Constipation Drugs Market, By Types |
6.1 Philippines Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 Philippines Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Philippines Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 Philippines Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 Philippines Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 Philippines Opioid Induced Constipation Drugs Market Key Performance Indicators |
9 Philippines Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 Philippines Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 Philippines Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Philippines Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Philippines Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Philippines Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 Philippines Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 Philippines Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |